Phase I SBIR grant from the National Eye Institute

Valitor has been awarded a Phase I SBIR grant from the National Eye Institute. This project is designed to apply our technology towards localized and sustained treatments in ophthalmology. Specifically, we will validate a long-acting anti-VEGF drug to treat diabetic macular edema.